About 3 results
Open links in new tab
6th Annual Evercore ISI HealthCONx Conference - ACELYRIN, INC.
The Investor Relations website contains information about ACELYRIN, INC.'s business for stockholders, potential investors, and financial analysts.
0001962918-24-000083 | 8-K | XBRL Viewer | Acelyrin INC
Acelyrin INC SEC filing: Form 8-K XBRL on 06/11/2024 (0001962918-24-000083).
LOS ANGELES, May 6, 2025 — ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines in …
Committee Composition | ACELYRIN, INC.
The Investor Relations website contains information about ACELYRIN, INC.'s business for stockholders, potential investors, and financial analysts.